Please assess the completion status of the following clinical trial:

Trial Title: Trial of Feedback on Blood Use

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients \>= 18 years old undergoing total hip arthroplasty or hip hemiarthroplasty~Exclusion Criteria:~* Refusal of blood transfusions~* Surgeons utilizing fast track protocols (planned discharge on postoperative day 1 or 2 following surgery.)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Feedback Arm (Type: EXPERIMENTAL): Orthopedic surgeons in the Feedback Arm will receive monthly reports providing individualized data on compliance with the FOCUS trial RBC transfusion guideline (pretransfusion Hb \<8 g/dL for hip surgery patients in the postoperative period.) Feedback data will be anonymized, but surgeons will be able to see their own data in comparison with their peers.
- Control Arm (Type: NO_INTERVENTION): Orthopedic surgeons in the Control Arm will not receive any feedback on their use of RBC transfusion in hip surgery patients.

Based on this trial design, predict the completion outcome and termination type (if applicable).